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Abstract
Objective: Post-hepatectomy liver failure (PHLF) is the major cause of death following liver resection.
The aim of this study was to evaluate the feasibility of an intraoperative simulation of post-resection liver
function.
Methods: Intraoperative liver function was measured by indocyanine green (ICG) clearance using the
LiMON™ technology. In 20 patients undergoing anatomic liver resection, ICG plasma disappearance rate
(PDR (%/min) and ICG retention at 15 min (R15) (%) were measured immediately after the induction of
anaesthesia (t0), after selective arterial and portovenous inflow trial clamping (TC) of the resected liver
segments (t1), after the completion of resection (t2) and before the closure of the abdominal cavity (t3).
Results: The median baseline (t0) PDR was 16.5%/min. Trial clamping of the inflow (t1) resulted in a
significant reduction in PDR to 10.5%/min. Results under TC were similar to those obtained after
resection (t2) (median PDR: 10.5%/min). Linear regression modelling showed that post-resection liver
volume could be accurately predicted by TC of liver inflow (P < 0.0001), but not by determining the
resected liver volume. Simulated post-resection liver function under TC correlated well with PHLF and
length of hospital stay.
Conclusions: Intraoperative ICG clearance measurements allow real-time monitoring of intraoperative
liver function during surgery. Trial clamping of arterial and portovenous inflow accurately predicts immedi-
ate post-resection liver function. The intraoperative measurement of liver function and simulation of
post-resection liver function may help to avoid PHLF.
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Introduction
Although major liver resection has become safer as a result of
advances in surgical techniques and perioperative management,
the resection of a large amount of functional liver tissue con-
tinues to bear risk for post-hepatectomy liver failure (PHLF).1,2
In individuals with normal liver parenchyma, the remnant
functional liver mass can be as low as 20–25%. Pre-existing liver
diseases (steatosis, fibrosis and cirrhosis) and intensified preop-
erative chemotherapy significantly reduce this functional liver
reserve,3 even to the point at which liver resection seems
impossible.
In order to prevent the occurrence of PHLF, various methods of
determining liver function have been established, all of which
measure the function of the entire liver preoperatively.4–6
However, the surgeon’s interest refers to the function of the
remnant liver after the resection, rather than the function of liver
that is to be resected. Therefore, predicting the function of the
future liver remnant is important and all the more so because
function cannot be assumed to be distributed homogeneously
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throughout the liver parenchyma.7,8 Depending on entity, size and
grade of differentiation, tumours may or may not contribute to
liver function.9,10 Tumours may also change the perfusion of
healthy liver parenchyma by diverting blood flow and disturb
biliary excretion by local compression.11 Finally, liver resections
along anatomic resection lines may differentially affect remnant
liver function according to individual liver anatomy.9
To account for the inaccuracies of conventional methods for the
preoperative determination of liver function, the present group
has established intraoperative indocyanine green (ICG) clearance
measurements for real-time measurements of liver function. This
paper reports the results of tests to establish whether liver function
under trial clamping (TC) of arterial and portovenous inflow




This pilot study prospectively included 20 patients undergoing
anatomic liver resection (two or more segments) between Febru-
ary 2013 and February 2014. Another prerequisite for inclusion
required the selective clamping of the arterial and portovenous
inflow to be possible.
Surgery and intraoperative ICG pulse
spectrophotometry
Liver resection was carried out using a standard open or
laparoscopic-assisted ultrasound dissection technique along the
anatomic borders defined by Couinaud’s liver segments. The
hepatic ligament was dissected to allow for the identification and
selective clamping of the arterial and portovenous inflow of the
liver segments scheduled for resection. Resection was performed
without a Pringle manoeuvre.
Indocyanine green clearance was determined intraoperatively
by non-invasive pulse spectrophotometry (LiMON™; Pulsion
Medical Systems AG, Munich, Germany). For each measurement,
an aqueous solution of ICG 0.25 mg/kg body weight was injected
i.v. Baseline liver function was obtained after the induction of
general anaesthesia (t0). The next measurement was obtained
under inflow TC in order to simulate the situation after resection
(t1). Post-resection liver function was measured after the comple-
tion of resection prior to the closure of the abdominal incision (t2)
(Fig. 1).
Study endpoints
Intraoperative ICG measurements of liver function were
expressed as the plasma disappearance rate (PDR) (%/min) and
the rate of retention after 15 min (R15). Other markers of liver
function, such as the international normalized ratio (INR), serum
bilirubin (‘50–50 criteria’12) and the laboratory Model for End-
stage Liver Disease (labMELD) score13 were recorded prior to
surgery and on postoperative days (PoD) 3 and 5. Post-
hepatectomy liver failure was defined as an increased INR with
concomitant hyperbilirubinaemia from PoD 5 onwards as sug-
gested by the International Study Group of Liver Surgery
(ISGLS).13
Volumetric data were calculated from preoperative computed
tomography (CT) scans. Preoperative total liver volume was
measured using the volumetry function of the open-source soft-
ware OsiriX® (Pixmeo SARL, Geneva, Switzerland). Resection
volumes were measured by water displacement. To compensate
for the lower volume of exsanguinated liver tissue, 13% was added
as suggested by Niehues et al.14 The remnant liver volume was
calculated by subtracting the resected volume from the total liver
volume.
t0 prior to clamping
= total liver function
t1 trial clamping of arterial and portovenous inflow
= predicted post-resection liver function
t1 after liver resection
= remnant liver function
Figure 1 Trial clamping in a right hemi-hepatectomy. This schematic drawing shows the inflow clamping of the right portal vein (pv) and the
right hepatic artery (ha) in preparation for an intended right hepatectomy with a resection line slightly right of the middle hepatic vein.
Indocyanine green clearance was determined prior to resection (t0), under trial clamping (t1) and after resection (t2)
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Patient characteristics, operative details, laboratory parameters
and data on the postoperative course were extracted from elec-
tronic patient charts and documented.
Statistical analyses
Unless otherwise indicated, all values are presented as the median
(range). For statistical analyses and graphics, GraphPad Prism
Version 6.0 (GraphPad Software, Inc., La Jolla, CA, USA) was
used. Differences in continuous parameters were determined by
Student’s t-tests. Linear regression analysis was used to determine
correlations between liver volume and function. A P-value of
<0.05 was considered to indicate statistical significance.
Results
Patient characteristics
Twenty patients with primary and secondary liver tumours were
included. Patient characteristics are detailed in Table 1. The sever-
ity of pre-existing liver disease was extracted from the postopera-
tive pathological report of the resected liver parenchyma and is
summarized in Table S1 (online). Haemodynamic differences,
as a relevant source of changes in intraoperative ICG measure-
ments, could be excluded. There were no clinically relevant differ-
ences in mean arterial pressure or central venous pressure between
t1 and t3.
Intraoperative ICG pulse spectrophotometry
The median PDR at t0 was 16.5%/min; values ranged from 9.9%/
min to 35.1%/min, reflecting the actual heterogeneity of baseline
liver function. In most patients TC (t1) resulted in a significant
reduction in PDR to a median of 10.5%/min (range: 4.7–20.0%/
min). The median value obtained after resection at t2 was 10.5%/
min (range: 4.7–20.0%/min) and thus was similar to that obtained
under TC. Inversely, median R15 was 8.2% (range: 0.5–22.7%) at
baseline, increased to 20.7% (range: 5.0–49.5%) at t1 and subse-
quently to 27.7% (range: 6.5–32.0%) at t2. Results are summarized
in Fig. 2. Individual measurements are shown in Table S1
(online).
Trial clamping accurately predicted liver function after resec-
tion as determined by linear regression modelling (P < 0.0001) of
PDR values measured under TC and after resection (Fig. 3a). No
correlation was found for preoperative measurements of total
PDR and post-resection PDR (Fig. 3b).
Further, measured liver function after resection did not corre-
late with calculated post-resection liver function as determined by
the percentage of liver resected and total liver function prior to
resection (Fig. 3c). Thus, the determination of post-resection liver
function by combining data for preoperative liver function and
volumetric assessment of resection planes is highly inaccurate.
Postoperative course
Patients who experienced PHLF (n = 6) according to the defini-
tion of the ISGLS13 showed significantly higher R15 values under
TC than did patients without PHLF (Fig. 4). Consequently,
patients with PHLF also had a significantly longer hospital stay
than patients without PHLF (Fig. 5).
Surgical complications of Clavien–Dindo Grade IIIb or greater
occurred in three patients. Two patients died in the postoperative
course, one (Patient 9) as a result of the rapid tumour progress of
a fibrolammelar hepatocellular carcinoma on PoD 129 and
another (Patient 5) secondary to PHLF on PoD 21.
One patient (Patient 3) required an operative thrombectomy
and revision of the portal vein on PoD 3.
Discussion
Liver resection provides the chance for cure in patients with early-
stage primary liver tumours and metastatic colorectal cancer con-
fined to the liver. In order to achieve the goal of a radical resection
with tumour-free margins, liver resection up to the limit of the
functional liver reserve is justified. Unfortunately, regenerative
capacity is not fixed, but depends on various factors including
haemodynamics, parenchymal integrity and the functional
reserve of the future liver remnant.15




Age, years, median (range) 60 (23–84)
Disease, n
Hepatocellular carcinoma 5




Hepatitis B, n 2
Hepatitis C, n 1
Non-hepatitis B/non-hepatitis C, n 17
Operation, n
Right hemi-hepatectomy 14
Extended right hemi-hepatectomy 3
Left hemi-hepatectomy 1
Left lateral segmentectomy 2
Total liver volume, ml, median (range) 1702 (1290–3473)
Resected liver volume, ml, median (range) 840 (213–2500)
Remnant liver volume, ml, median (range) 940 (610–1873)
Postoperative hospital stay, days, median
(range)
14 (6–129)
Preoperative MELD score, median (range) 7 (6–15)
Postoperative MELD score at PoD 3, median
(range)
10 (7–22)
Postoperative MELD score at PoD 5, median
(range)
8 (6–23)
MELD, Model for End-stage Liver Disease; PoD, postoperative day.
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Currently, decisions on whether or not to perform the required
resection rely on the preoperative assessment of full liver function
and on the intraoperative judgement of an experienced
hepatobilary surgeon. However, postoperative liver failure still
occurs in 5–8% of patients.
A major source of misjudgement derives from the fact that
postoperative remnant liver function cannot be extrapolated by
preoperative liver function tests. There are several reasons for this.
Firstly, liver function may already be compromised below the
detection limit of conventional markers. The half-life of liver
function markers used in routine clinical practice is too long to
support intraoperative real-time measurements of liver function.
Secondly, liver function is influenced by haemodynamics in the
remnant liver tissue. Liver resection may also compromise liver in-
and outflow distant of the resection line; large tumours in par-
ticular can divert blood flow significantly. Thirdly, liver volume
may not necessarily correlate with function.
The present study suggests that, in individual patients, the
intraoperative measurement of hepatic function with ICG
spectrophotometry adds an objective intraoperative real-time
parameter to facilitate decision making.16 Under TC of arterial
and portal venous inflow, measured liver function closely resem-
bles liver function after resection. Trial clamping resulted in a
significant decline in PDR and an increase in R15 values. Values
under TC and after resection were very similar. Liver function
under TC was clinically relevant because changes corresponded
well with changes between pre- and postoperative labMELD
scores on PoD 3, the occurrence of PHLF and hospital length of
stay.
Measured liver function after TC closely reflected liver function
after resection. The linear regression analysis revealed a clear
numerical correlation between liver function prior to resection
under TC and liver function after resection. By contrast, the cor-
relation between liver function extrapolated from CT volumetry
and actual PDR measured in the remnant liver was poor. Refine-
ment of volumetric measurement by various correction factors,
such as by subtracting tumour volume in some tumour entities,
may increase accuracy, but may also fail to resemble liver function.
Therefore, the extrapolation of volumetric full liver data is inferior
to direct measurement under TC.
This method is limited by its restriction to anatomic resections
and the underestimation of liver function in patients with severe
bilary obstruction.5 In addition, the present study is limited by the
low number of patients included. In order to generate sufficient
data to determine a clear cut-off value, an appropriately powered
prospective study should be conducted.
To date, no clear cut-off values have been established. Cheung
et al. suggest a preoperative cut-off R15 value of 14% for safe
resections in patients with Child–Pugh class A cirrhosis.17 de
Liguori Carino et al. established a preoperative PDR cut-off of
17.6%/min.18 In their population, the median PDR value on
PoD 1 in patients who subsequently developed liver dysfunction
was 6.7%/min (interquartile range: 6.3–10.4%/min), suggesting
that a PDR value of <10%/min may indicate a borderline liver
reserve. After liver transplantation, a PDR value of <12.85%/min
at any time between PoD 0 and PoD 5 was shown to be predictive
of early severe complications, primary non-function of the graft
or acute rejection.19 Schneider et al. suggest a PDR cut-off value of
9.6%/min on PoD 7 predicts death and graft loss in liver trans-
plant patients.20 Hori et al. established a cut-off ratio of 3.1175 for
ICG to graft weight for an adequate donor cell mass to avoid
small-for-size grafts in living donor liver transplantation.21
The measurement of liver function under TC offers additional
information to the hepatobilary surgeon who must decide
whether to adapt the surgical strategy. In addition to the option
to abort the procedure, the surgeon may decide to use a
Figure 2 Intraoperative simulation of remnant liver function [mean ± standard error of the mean (SEM)] indocyanine green (ICG) plasma
disappearance rate (PDR) and ICG clearance rate at 15 min (R15)
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parenchyma-sparing non-anatomic resection, convert to a two-
stage procedure or use an in situ split technique.
Thus, this simple method may allow the intraoperative reassess-
ment of liver function under realistic conditions and may facilitate
decision making in patients with critically small liver remnants
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Figure 3 Correlations between (a) indocyanine green (ICG) plasma
disappearance rate (PDR) measured preoperatively and post-
resection (r = 0.3589, r2 = 0.1288, P = 0.1202), (b) ICG PDR at
clamping and at post-resection (r = 0.8045, r2 = 0.6473, P < 0.0001),
and (c) the percentage of ICG PDR at t2/t0 and the percentage of















Figure 4 Intraoperative indocyanine green clearance rate at 15 min



























Figure 5 Postoperative hospital stay in patients with and without
post-hepatectomy liver failure (PHLF)
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Table S1 Liver function test before surgery, intraoperatively at t0 (preclamping,
total liver), t1 (trial clamping, remnant liver), t2 (after resection, actual remnant
liver) and on postoperative days 3 and 5.
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